Methylcyclopentadiene is a cyclic diene, meaning it contains two double bonds within a ring structure. It's a key intermediate in the synthesis of various industrially important compounds, including polymers, pharmaceuticals, and agrochemicals. The compound exists in two isomeric forms: 1-methylcyclopentadiene and 2-methylcyclopentadiene. Its reactivity arises from the conjugated double bonds and the inherent instability of the cyclopentadiene ring system. The instability leads to a tendency for dimerization, forming various Diels-Alder adducts. This property makes it a valuable building block for creating complex organic structures. Methylcyclopentadiene is studied due to its significance in synthetic chemistry and its potential applications in diverse fields. Research focuses on its synthesis, characterization, and its utilization in various reactions, including Diels-Alder cycloadditions, ring-opening metathesis polymerization, and the formation of new materials.'
methylcyclopentadiene: RN given refers to cpd with unspecified methyl-locant
ID Source | ID |
---|---|
PubMed CID | 66775 |
MeSH ID | M0092082 |
Synonym |
---|
1,3-cyclopentadiene, methyl- |
1-methyl-1,3-cyclopentadiene |
1,3-cyclopentadiene, 1-methyl- |
einecs 247-757-5 |
nsc 157581 |
monomethylcyclopentadiene |
nsc-157581 |
26519-91-5 |
methylcyclopentadiene |
1-methylcyclopenta-1,3-diene |
k4o53gr393 , |
96-39-9 |
unii-k4o53gr393 |
1-methylcyclopentadiene |
cyclopentadiene, methyl- |
FT-0628868 |
methyl cyclopentadiene |
l,3-cyclopentadiene,1-methyl- |
AKOS028110097 |
Q5094303 |
cyclopentadiene, 1-methyl- |
DTXSID101027739 |
Methylcyclopentadiene (MCP) is an example of a highly reactive and hazardous compound.
Excerpt | Reference | Relevance |
---|---|---|
"Methylcyclopentadiene (MCP) is an example of a highly reactive and hazardous compound in the chemical process industry." | ( Molecular simulation studies on chemical reactivity of methylcyclopentadiene. Mannan, MS; Rogers, WJ; Wang, Q; Zhang, Y, 2009) | 1.32 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (34.24) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (14.29%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (85.71%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |